Japan Antiinfective Medicine Sales is set to reach $664.41 Million by 2026 from $1,210 Million, will fall by 8.9% per year. Germany, South Korea and Italy respectively ranked numbers 2, 3 and 4 in this ranking.
How does Japan perform in Anti-Infective?
Penicillins and Streptomycins in Bulk Market Size Value in Japan
- US Dollars
- 2010 to 2023
- ReportLinker Research
Hormones in Dosage Except Contraceptives and Antibiotics Market Size Value Per Capita in Japan
- US Dollars
- 2009 to 2023
- ReportLinker Research
Hormones in Dosage Except Contraceptives and Antibiotics Market Size Value in Japan
- US Dollars
- 2009 to 2023
- ReportLinker Research
Penicillins and Streptomycins in Bulk Market Size Value Per Capita in Japan
- US Dollars
- 2010 to 2023
- ReportLinker Research
Forecast: Antiinfective Medicine Sales in Japan
- Million Japanese Yens
- 2024 to 2028
- ReportLinker Research
Forecast: Antiinfective Medicine Sales in Japan
- US Dollars Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Antiinfective Medicine Sales in Japan
- Million US Dollars PPP
- 2024 to 2028
- ReportLinker Research
Forecast: Antiinfective Medicine Sales in Japan
- US Dollars PPP Per Capita
- 2024 to 2028
- ReportLinker Research
Forecast: Hormones in Dosage Except Contraceptives and Antibiotics Market Size Value Per Capita in Japan
- US Dollars
- 2024 to 2028
- ReportLinker Research
Forecast: Penicillins and Streptomycins in Bulk Market Size Value Per Capita in Japan
- US Dollars
- 2024 to 2028
- ReportLinker Research